Bioneer Competitors and Similar CompaniesClear all

Bioneer's competitors and similar companies include HepaRegeniX, Valanbio Therapeutics, Genomics and Nanjing King-Friend Biochemical Pharmaceutical.
Bioneer
Bioneer
Bioneer (바이오니아) is a company engaged in biotechnology research and development.
HepaRegeniX
HepaRegeniX
HepaRegeniX is a drugs developing company.
Valanbio Therapeutics
Valanbio Therapeutics
Valanbio Therapeutics is a company that develops anti-infective solutions.
Genomics
Genomics
Genomics is a company using genomic insights for drug development.
Nanjing King-Friend Biochemical Pharmaceutical
Nanjing King-Friend Biochemical Pharmaceutical
Nanjing King-Friend Biochemical Pharmaceutical (NKF, 南京健友生化制药股份有限公司) is a company that specializes in the research, production, and sales of medicines and health products.
Founding Date
Founding Date
1992
Founding Date
2016
Founding Date
2015
Founding Date
2014
Founding Date
2000
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Daejeon, KR HQ
Locations
Tübingen, DE HQ
Tübingen, DE
Locations
Durham, US HQ
Locations
Oxford, GB HQ
Cambridge, GB
Cambridge, US
Locations
Nanjing, CN HQ
Chengdu, CN
Cork, IE
Milano, IT
Altrincham, GB
Chicago, US
Employees
Employees
3628% decrease
Employees
15
Employees
5
Employees
1804% increase
Employees
1,3606% decrease

Financial

Revenue (est.)
Revenue (est.)
₩330.1b (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£2.8m (FY, 2019)
Revenue (est.)
¥4b (FY, 2025)
Cost of goods
Cost of goods
₩68b (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥2.4b (FY, 2025)
Gross profit
Gross profit
₩262.3b (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
¥1.5b (FY, 2025)
Net income
Net income
₩1.7b (FY, 2025)
Net income
N/A
Net income
N/A
Net income
(£2.5m) (FY, 2019)
Net income
¥581.5m (FY, 2025)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 12.2m (over 6 years ago)
Latest funding round
N/A
Latest funding round
$ 10.2m (over 7 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 21.2m
Total funding raised
N/A
Total funding raised
$ 61.9m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

HepaRegeniX
HQ
Tübingen, DE
Employees
15

HepaRegeniX is a drugs developing company.

View company
Valanbio Therapeutics
HQ
Durham, US
Employees
5

Valanbio Therapeutics is a company that develops anti-infective solutions.

View company
Genomics
HQ
Oxford, GB
Employees
180↑ 4% increase

Genomics is a company using genomic insights for drug development.

View company
Nanjing King-Friend Biochemical Pharmaceutical
HQ
Nanjing, CN
Employees
1,360↓ 6% decrease

Nanjing King-Friend Biochemical Pharmaceutical (NKF, 南京健友生化制药股份有限公司) is a company that specializes in the research, production, and sales of medicines and health products.

View company